You are here: Industry Insights > blood cancers

News List

HaemaLogiX raises $10 million to advance multiple myeloma treatments prnasia
September 13, 2021
HaemaLogiX Pty Ltd, a clinical stage biotech company developing novel immuno-oncology and immune therapies for patients with blood cancers, is pleased to both announce the close of a fully subscribed $10 million placement...
NCCN Meeting on Blood Cancers Will Be Virtual for the First Time prnasia
August 27, 2020
The National Comprehensive Cancer Network® (NCCN®) has announced this year's NCCN Annual Congress: Hematologic Malignancies™ will be fully online and open to all attendees at no cost.
Selvita announces first patient dosed in phase I/II clinical trial of SEL24 pharmaasia
April 05, 2017
Selvita announced that the first patient was dosed with SEL24 in a Phase I/II clinical trial, for acute myeloid leukemia (AML).
Nordic Nanovector sees interest from buyers as drug progresses firstwordpharma
February 21, 2017
Nordic Nanovector CEO Luigi Costa indicated that the company, which is developing new ways to treat blood cancers, has seen increasing interest from potential buyers, as reported in NASDAQ.